Privigen

STN: 125201
Proper Name: Immune Globulin Intravenous (Human), 10% Liquid
Tradename: Privigen
Manufacturer: CSL Behring AG, License #1766
Indication:

For the treatment of:

• Primary humoral immunodeficiency;
• Chronic immune thrombocytopenic purpura (ITP) in patients age 15 years and older;
• Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.

Product Information

• Package Insert - Privigen

Supporting Documents

• September 14, 2017 SBRA-Privigen
• September 14, 2017 Approval Letter - Privigen
• Supporting Documents older than three years - Privigen